BioCentury | Oct 1, 2020
Product Development

Sept. 30 Quick Takes: $234M for NIH’s RADx-UP; plus CureVac, Allena, Covaxx

...participants before year-end. Pontifax debt financing extends Allena’s runway A $25 million convertible note deal with Pontifax Medison...
BioCentury | Mar 17, 2020
Finance

With strengthened balance sheet, Keros is latest biotech looking to test IPO market

...round, investing alongside Pontifax, Arkin Bio Ventures, Partners Innovation Fund, Global Health Sciences Fund and Medison...
BioCentury | Aug 30, 2019
Finance

Pontifax investing $150M venture debt fund alongside crossovers

...roughly three years from that fund. Rajkomar said Pontifax is collaborating on the fund with Medison Pharma Ltd....
...operates its own venture fund; she declined to provide specific details on Pontifax's relationship with Medison. Paul...
BioCentury | Jan 11, 2019
Financial News

Venture roundup: Apic, Stelexis, Biond, Keros

...by Pontifax, with participation from fellow existing investors Arkin Bio Ventures, Partners Innovation Fund and Medison...
BioCentury | Jan 8, 2019
Financial News

Venture roundup: Apic, Stelexis, Biond, Keros

...by Pontifax, with participation from fellow existing investors Arkin Bio Ventures, Partners Innovation Fund and Medison...
BioCentury | Nov 26, 2018
Distillery Therapeutics

Cardiovascular

...clinical trials of Iclusig in CCM patients. Takeda Pharmaceutical Co. Ltd., Gruppo Angelini, Incyte Corp., Medison Pharma Ltd....
BioCentury | Aug 17, 2018
Financial News

Crossover investors join Orchard's syndicate in $150M series C

...RA Capital, Venrock, Foresite Capital, Perceptive Advisors, Cormorant Asset Management, ArrowMark Partners, Sphera Global Healthcare, Medison...
BioCentury | Aug 13, 2018
Financial News

Crossover investors join Orchard's syndicate in $150M series C

...RA Capital, Venrock, Foresite Capital, Perceptive Advisors, Cormorant Asset Management, ArrowMark Partners, Sphera Global Healthcare, Medison...
BioCentury | Jun 28, 2018
Distillery Therapeutics

Infectious disease

...the SCCs in models of MRSA infection. Eli Lilly and Co., Kuhnil Pharmaceutical Co. Ltd., Medison Pharma Ltd....
BioCentury | Mar 27, 2018
Distillery Therapeutics

Cancer; inflammation

...additional models of colorectal cancer and asthma. Takeda Pharmaceutical Co. Ltd., Gruppo Angelini, Incyte Corp., Medison Pharma Ltd....
Items per page:
1 - 10 of 27
BioCentury | Oct 1, 2020
Product Development

Sept. 30 Quick Takes: $234M for NIH’s RADx-UP; plus CureVac, Allena, Covaxx

...participants before year-end. Pontifax debt financing extends Allena’s runway A $25 million convertible note deal with Pontifax Medison...
BioCentury | Mar 17, 2020
Finance

With strengthened balance sheet, Keros is latest biotech looking to test IPO market

...round, investing alongside Pontifax, Arkin Bio Ventures, Partners Innovation Fund, Global Health Sciences Fund and Medison...
BioCentury | Aug 30, 2019
Finance

Pontifax investing $150M venture debt fund alongside crossovers

...roughly three years from that fund. Rajkomar said Pontifax is collaborating on the fund with Medison Pharma Ltd....
...operates its own venture fund; she declined to provide specific details on Pontifax's relationship with Medison. Paul...
BioCentury | Jan 11, 2019
Financial News

Venture roundup: Apic, Stelexis, Biond, Keros

...by Pontifax, with participation from fellow existing investors Arkin Bio Ventures, Partners Innovation Fund and Medison...
BioCentury | Jan 8, 2019
Financial News

Venture roundup: Apic, Stelexis, Biond, Keros

...by Pontifax, with participation from fellow existing investors Arkin Bio Ventures, Partners Innovation Fund and Medison...
BioCentury | Nov 26, 2018
Distillery Therapeutics

Cardiovascular

...clinical trials of Iclusig in CCM patients. Takeda Pharmaceutical Co. Ltd., Gruppo Angelini, Incyte Corp., Medison Pharma Ltd....
BioCentury | Aug 17, 2018
Financial News

Crossover investors join Orchard's syndicate in $150M series C

...RA Capital, Venrock, Foresite Capital, Perceptive Advisors, Cormorant Asset Management, ArrowMark Partners, Sphera Global Healthcare, Medison...
BioCentury | Aug 13, 2018
Financial News

Crossover investors join Orchard's syndicate in $150M series C

...RA Capital, Venrock, Foresite Capital, Perceptive Advisors, Cormorant Asset Management, ArrowMark Partners, Sphera Global Healthcare, Medison...
BioCentury | Jun 28, 2018
Distillery Therapeutics

Infectious disease

...the SCCs in models of MRSA infection. Eli Lilly and Co., Kuhnil Pharmaceutical Co. Ltd., Medison Pharma Ltd....
BioCentury | Mar 27, 2018
Distillery Therapeutics

Cancer; inflammation

...additional models of colorectal cancer and asthma. Takeda Pharmaceutical Co. Ltd., Gruppo Angelini, Incyte Corp., Medison Pharma Ltd....
Items per page:
1 - 10 of 27